YOLK SAC TUMOR
Clinical trials for YOLK SAC TUMOR explained in plain language.
Never miss a new study
Get alerted when new YOLK SAC TUMOR trials appear
Sign up with your email to follow new studies for YOLK SAC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancer: sirolimus combo shows promise
Disease control CompletedThis study tested a new combination of drugs (sirolimus plus chemotherapy) in 32 children with recurrent or refractory yolk sac tumors, a rare type of germ cell tumor. The goal was to see if the combination could shrink tumors and improve survival. The treatment was given in cycl…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE2, PHASE3 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:11 UTC
-
Old drug, new hope: thalidomide combo shows promise for kids with rare cancer
Disease control CompletedThis completed phase 2 trial tested a combination of thalidomide and three chemotherapy drugs (nab-paclitaxel, gemcitabine, epirubicin) in 20 children with relapsed or refractory yolk sac tumor, a rare germ cell cancer. The goal was to see if this new mix could shrink tumors or l…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 17:46 UTC